Aflibercept/bevacizumab/triamcinoloneLack of efficacy during treatment of macular oedema secondary to central retinal vein occlusion: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1896卷 / 1期
关键词：
D O I：
10.1007/s40278-022-10817-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：26 / 26
相关论文
共 50 条
  • [1] Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
    T D Papakostas
    L Lim
    T van Zyl
    J B Miller
    B S Modjtahedi
    C M Andreoli
    D Wu
    L H Young
    I K Kim
    D G Vavvas
    D D Esmaili
    D Husain
    D Eliott
    L A Kim
    Eye, 2016, 30 : 79 - 84
  • [2] Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
    Papakostas, T. D.
    Lim, L.
    van Zyl, T.
    Miller, J. B.
    Modjtahedi, B. S.
    Andreoli, C. M.
    Wu, D.
    Young, L. H.
    Kim, I. K.
    Vavvas, D. G.
    Esmaili, D. D.
    Husain, D.
    Eliott, D.
    Kim, L. A.
    EYE, 2016, 30 (01) : 79 - 84
  • [3] Comment on: 'Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab'
    Calugaru, D.
    Calugaru, M.
    EYE, 2016, 30 (05) : 766 - 766
  • [4] Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’
    T D Papakostas
    D Vavvas
    D Eliott
    L A Kim
    Eye, 2016, 30 : 766 - 767
  • [5] EFFECTS OF SWITCHING TO AFLIBERCEPT IN THE TREATMENT OF MACULAR OEDEMA SECONDARY TO RETINAL VEIN OCCLUSION
    Spooner, Kimberly
    Hong, Thomas
    Fraser-Bell, Samantha
    Chang, Andrew
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 : 124 - 124
  • [6] EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
    Lotfy, Ayman
    Solaiman, Kamal A. M.
    Abdelrahman, Ayman
    Samir, Ahmed
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (09): : 1795 - 1800
  • [7] Aflibercept versus ranibizumab for cystoid macular oedema secondary to central retinal vein occlusion
    Karampelas, Michael
    Waxman, Jacob
    Barampouti, Foteini Faye
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [8] COST-EFFECTIVENESS OF AFLIBERCEPT IN THE TREATMENT OF MACULAR OEDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION IN SWEDEN
    Eriksson, M.
    Castelo-Branco, A.
    Nilsson, J.
    VALUE IN HEALTH, 2014, 17 (07) : A608 - A608
  • [9] Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion
    Kreutzer, T. C.
    Alge, C. S.
    Wolf, A. H.
    Kook, D.
    Burger, J.
    Strauss, R.
    Kunze, C.
    Haritoglou, C.
    Kampik, A.
    Priglinger, S.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (03) : 351 - 355
  • [10] Aflibercept: A Review in Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Hoy, Sheridan M.
    DRUGS & AGING, 2017, 34 (05) : 393 - 400
12345